U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07558707) titled 'Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice' on March 31.
Brief Summary: This study is a prospective, multi-center, observational study to evaluate the efficacy and safety of Fexuclue Tablet 20 mg in patients requiring prevention of NSAIDs-induced peptic ulcer in real-world clinical practice in Korea.
Patients receiving NSAIDs and requiring gastroprotective therapy will be enrolled and followed prospectively. The study will assess patient-reported outcomes (PROs) related to gastrointestinal symptoms, as well as safety outcomes.
Study Start Date: April 30
Study Type: OBSERVATIONAL
Condition:
Pepti...